作者: Kiyoshi Misawa , Takeharu Kanazawa , Yuki Misawa , Atsushi Imai , Takayuki Uehara
DOI: 10.1007/S00432-013-1393-5
关键词: Oncology 、 DNA methylation 、 Head and neck cancer 、 Internal medicine 、 Cancer research 、 Tachykinin receptor 、 Hematology 、 Biomarker (medicine) 、 Methylation 、 Head and neck squamous-cell carcinoma 、 Medicine 、 TAC1
摘要: Aim The aim of this study was to define TAC1 and TACR1 methylation profiles for head neck squamous cell carcinoma (HNSCC) tumors at diagnosis follow-up evaluate their prognostic significance value as a biomarker recurrence.